Idiopathic hypersomnia is a neurological sleep disorder characterised by excessive daytime sleepiness despite getting a full ...
Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT 1A agonist. It is currently approved under the brand name Sunosi ® to improve ...
Proper diagnosis and treatment can help manage both the condition and the associated fatigue. Excessive daytime sleepiness can significantly impact your quality of life, affecting your work ...
NEW YORK, Nov. 6 (UPI) --Experiencing excessive daytime sleepiness as an older adult can spell dire consequences that ...
What is your approach when patients report being impaired by daytime sleepiness? Take this quiz, based on recent literature, to determine if you’re up to date on this topic. At the end of the ...
This finding adds to existing research, which has previously connected sleep patterns to dementia risk. One research published in the Alzheimer's and Dementia journal in 2016 disclosed that either too ...
Perspective from Christopher M. Carosella, MD Among patients with obstructive sleep apnea and excessive daytime sleepiness-related cognitive impairment, 2-week solriamfetol led to cognitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results